Exact Sciences Corp EXAS:NASDAQ

Last Price$85.46NASDAQ Previous Close - Last Trade as of 1:00PM ET 11/26/21

Today's Change-2.63(2.99%)
Bid (Size)$85.25 (1)
Ask (Size)$87.35 (2)
Day Low / High$85.03 - 90.39
Volume1.3 M

View Biotechnology IndustryPeer Comparison as of 11/26/2021


Exact Sciences Corp ( NASDAQ )

Price: $85.46
Change: -2.63 (2.99%)
Volume: 1.3 M
1:00PM ET 11/26/2021

Novavax Inc ( NASDAQ )

Price: $217.97
Change: +17.90 (8.95%)
Volume: 6.2 M
1:00PM ET 11/26/2021

Repligen Corp ( NASDAQ )

Price: $286.01
Change: +14.17 (5.21%)
Volume: 438.4 K
1:00PM ET 11/26/2021

Incyte Corp ( NASDAQ )

Price: $68.38
Change: +1.64 (2.46%)
Volume: 3.2 M
1:00PM ET 11/26/2021

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $87.58
Change: -1.99 (2.22%)
Volume: 1.0 M
1:00PM ET 11/26/2021

Read more news Recent News

Exact Sciences Says New Data in Clinically Low-Risk Prostate Cancer Patients Backs Use of Oncotype DX Test
11:04AM ET 11/23/2021 MT Newswires

Exact Sciences (EXAS) said Tuesday results from a new 20-year study validated adverse pathology as a predictor of prostate cancer outcomes in clinically...

Exact Sciences Partners With Jefferson Health on Multi-Cancer Earlier Detection Test Research
11:10AM ET 11/18/2021 MT Newswires

Exact Sciences (EXAS) said Thursday it partnered with Philadelphia-based primary-care provider Jefferson Health for research on a new blood-based,...

Insider Sell: Exact Sciences
5:48PM ET 11/03/2021 MT Newswires

Kevin T Conroy, Director, President and CEO, on November 01, 2021, sold 16,922 shares in Exact Sciences (EXAS) for $1,588,637. Following the Form 4 filing...

--BTIG Adjusts Exact Sciences' Price Target to $120 From $145, Reiterates Buy Rating
11:27AM ET 11/03/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionEXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI. View company web site for more details
Address5505 Endeavor Lane
Madison, Wisconsin 53719
Number of Employees1,977
Recent SEC Filing11/05/20213
Chairman, President & Chief Executive OfficerKevin T. Conroy
Senior Vice President-OperationsAna Hooker
Executive VP, Chief Operating & Financial OfficerJeffrey Thomas Elliott
Chief Science Officer, SVP-Research & DevelopmentGraham Peter Lidgard

Company Highlights

Price Open$89.16
Previous Close$88.09
52 Week Range$81.07 - 159.54
Market Capitalization$14.7 B
Shares Outstanding172.3 M
SectorHealth Technology
Next Earnings Announcement02/15/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.80
Beta vs. S&P 500N/A
Revenue$454.5 M
Net Profit Margin-46.14%
Return on Equity-24.07%

Analyst Ratings as of 11/11/2021

Consensus RecommendationConsensus Icon
Powered by Factset